Font Size: a A A

Effect Of Atorvastatin Calcium On Proliferation And OPG/RANKL System Of Osteoblast

Posted on:2012-06-08Degree:MasterType:Thesis
Country:ChinaCandidate:L SunFull Text:PDF
GTID:2154330335477026Subject:Internal Medicine
Abstract/Summary:PDF Full Text Request
Background:Statins is used to lower blood cholesterol at present clinically,but a retrospectie study showed that statins can not only make older women blood cholesterol decline,but also can make their hip density increase significantly. It hints that statin can improve the bone mineral density. The OPG/RANKL system is a newly discovered ,which plays an important role in the pathogenesis and treatment of osteoporosis.Objective:To research the effect of different concentrations atorvastatin calcium on cell proliferation and OPG(osteoprotegerin), RANKL(receptor activator of nuclear factor-κΒligand), M-CSF(macrophage-colony stimulating factor) gene expression of osteoblast in vitro,to explore the molecular mechanism of atorvastatin calcium anti osteoporosis,and to provide the experiment basis for clinical drug use. Methods:(1) The crinial bones were digesting by mixed enzyme which contains enzyme andⅠtype collagenase.The osteoblast were purified by selective plating technique. The osteoblasts were identified through morphlogy observation, alkaline phosphatase dyeing, collagenⅠimmunohistochemical staining. (2) The second generation of osteoblasts is employed. With different concentrations of atorvastatincalcium(10-9 ,10-8 ,10-7,10-6,10-5mol/L)intervention osteoblasts, the cell proliferation is assayed using MTT after 24h,48h,72h. (3)With different concentrations of atorvastatin calcium(10-9 ,10-8 ,10-7,10-6,10-5mol/L) intervention osteoblasts,the gene expression of OPGmRNA,RANKLmRNA, M-CSFmRNA was measured by Real-time fluorescence quantitative PCR. (4) Statistical methods: Experimental data are used mean±standard deviation to show ,SPSS17.0 statistical software is applied for statistical analysis.Single factor analysis of variance (ANOVA) is used for comparison between groups,when P﹤0.05, there were significant differences. Results:(1)The cultured cells have the typical features of osteoblast.The cells are triangle, polygonal, long spindle shape, etc.and mostly are mononuclear cells, have large pseudopodia.Alkaline phosphatase dyeing collagenⅠimmunohistochemical staining are both positive.(2) The result of MTT method shows that it hasn't statistically significant differences (P > 0.05) with different concentrations of atorvastatin calcium (10-9 ,10-8 ,10-7,10-6,10-5mol/L) processing rat osteoblasts 24 hours. The medication groups'OD value are greater than the control group with different concentrations of atorvastatin calcium (10-9 ,10-8 ,10-7.10-6,10-5mol/L) processing rat osteoblasts 48,72hours, it has statistically significant differences while the meication concentration are10-9 ,10-8 ,10-7 ,10-6mol/L (P﹤0.05), but it has not statistically significant differences among medication groups. (3) The result of real-time fluorescence quantitative polymerase chain reaction (PCR) shows that atorvastatin calcium (10-9 ,10-8 ,10--7,10-6,10-5mol/L) can promote OPG and M-CSF gene mRNA expression, restrain RANKL gene mRNA expression, and this effect may be concerned with medication'concentration and time.Conclusion:(1)A large quantity and activity of the good cells were obtained by mixed enzyme digestion method. High purity osteoblasts were obtained by selective plating technique that can remove impurities such as fibroblast cells.(2)Atorvastatin calcium can promote the osteoblast proliferation.Atorvastatin calcium can promote OPG and M-CSF gene's expression of osteoblast, inhibit RANKL gene's expression of osteoblast. These may be the important mechanism that atorvastatin calcium resistance of osteoporosis.
Keywords/Search Tags:Osteoprotegerin, receptor activator of nuclear factor-κB ligand, receptor activator of nuclear factor-κB, macrophage-colony stimulating factor, Atorvastatin calcium, osteoporosis
PDF Full Text Request
Related items
Association Between Serum Osteoprotegerin/Receptor Activator Of Nuclear Factor KappaB Ligand,25-(OH)VitD3Levels And Osteoporosis With Type2Diabetes Mellitus
Effects Of Pinoresinol Di-O-β-D-glucopyranoside On The Expressions Of Receptor Activator Of Nuclear Factor-κB Ligand And Osteoprotegerin In Murine Osteoblasts MC3T3-E1in Vitro
Effect Of Overexpression Of M-CSF And RANKL Gene On Related Bone Remodeling Factors
Effect Of Triptolide On Expression Of Receptor Activator Of Nuclear Factor-κB Ligandin Rat Adjuvant Induced Arthritis.
The Protective Role And Mechanism Of Cyclopropanyldehydrocostunolide In High Glucose-induced Podocytes On The Base Of RANKL/RANK-mediated NF-κB And MAPK Pathways
Part I The Relative Expression Of Receptor Activator Of Nuclear Factor-Kappa B Ligand And Osteoprtegerin MRNA In Bone Tissue In Ovariectomized Mice
The Levels And Significance Of Receptor Activator Of Nuclear Factor-KB Ligand?Tumor Necrosis Factor-??Osteoprotegerin In Serum For Patients With Psoriasis Vulgaris
A Study On Osteoprotegerin Ligand And Receptor Activator Of Nuclear Factor κ-B Express During The Replacement Of Dogs' Primary And Permanent Teeth
Effects Of Curcumin On Bone Mineral Density And Osteoprotegerin And Receptor Activator Of Nuclear Factor-κB Ligand Protein Expression In Rats With Adjuvant Arthritis
10 The Research On Relationship Between The Serum Osteoprotegerin/Receptor Activator Of Nuclear Factor-κB Ligand And Osteoporosis In Postmenopausal Women